about
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-AntagonistsSTAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling PathwaysDeep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis.Studying human immunodeficiencies in humans: advances in fundamental concepts and therapeutic interventions.Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.Within host RNA virus persistence: mechanisms and consequences.Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.Type I Interferons in Newborns-Neurotoxicity versus Antiviral Defense.A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations.Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20).Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.A systematic approach to the development of a safe live attenuated Zika vaccine.
P2860
Q26745547-7BA8F1F7-CC3B-4E91-91FD-2F139AB7EE6BQ36174010-AB4CF67A-E24F-449B-886A-D1CC3126529CQ37553441-E0CF8C41-A9FD-4AAE-BC09-1481A3B604F7Q37730201-BB66817C-0BE4-42DE-BEAB-6E33FA987092Q38733510-0930B2E8-6CF0-4239-99DE-D99A96E57B8EQ39188201-BD5876FF-3458-451A-8CB2-E13E7EFE70C1Q39222478-BFCF904A-3544-4FB1-A47A-2B9D8BCC8FA9Q40044232-A6CB765D-6B0E-4F9D-B677-888FF4FFD455Q40670500-BF9184CA-6F79-4552-880C-AF42160F217FQ47438235-62060ADF-9A1B-407D-B67C-511F4560D81FQ47849296-8FE3B549-7B8C-4468-840D-01335D39F99EQ48221758-08BF4EA9-835C-43D1-AB1B-2F664B89D3C9Q51336360-B9601ED9-DECF-40E6-8974-D8E3A12CB684
P2860
description
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2015
@ast
im September 2015 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2015/09/30)
@sk
vědecký článek publikovaný v roce 2015
@cs
wetenschappelijk artikel (gepubliceerd op 2015/09/30)
@nl
наукова стаття, опублікована у вересні 2015
@uk
مقالة علمية (نشرت في 30-9-2015)
@ar
name
Human IFNAR2 deficiency: Lessons for antiviral immunity
@ast
Human IFNAR2 deficiency: Lessons for antiviral immunity
@en
Human IFNAR2 deficiency: Lessons for antiviral immunity
@nl
type
label
Human IFNAR2 deficiency: Lessons for antiviral immunity
@ast
Human IFNAR2 deficiency: Lessons for antiviral immunity
@en
Human IFNAR2 deficiency: Lessons for antiviral immunity
@nl
prefLabel
Human IFNAR2 deficiency: Lessons for antiviral immunity
@ast
Human IFNAR2 deficiency: Lessons for antiviral immunity
@en
Human IFNAR2 deficiency: Lessons for antiviral immunity
@nl
P2093
P2860
P50
P3181
P1476
Human IFNAR2 deficiency: Lessons for antiviral immunity
@en
P2093
Andrew J Cant
Andrew J Skelton
Cathy McMahon
Dan F Young
Diane C Munday
Jeff Connell
Karin R Engelhardt
Karina M Butler
Manoj Valappil
Mike Hubank
P2860
P304
P3181
P356
10.1126/SCITRANSLMED.AAC4227
P407
P50
P577
2015-09-30T00:00:00Z